Thrombotic event prevention in patients with post-infarction chronic heart failure, as а part of complex therapy including various classes of beta -adrenoblockers

Thrombotic event prevention in patients with post-infarction chronic heart failure, as а part of complex therapy including various classes of beta -adrenoblockers

Aim. To compare carvedilol and metoprolol tartrate effects on hemostasis in patients with post-infarction chronic heart failure (CHF), receiving complex therapy. To study deep venous thrombosis (DBT) incidence in CHF patients without additional risk factors (RFs) for venous thrombosis.Material and m...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Yu. V. Larina, L. A. Nekrutenko, A. V. Tuev, A. V. Agafonov, I. P. Rubesh
Μορφή:	Άρθρο
Γλώσσα:	Russian
Έκδοση:	«SILICEA-POLIGRAF» LLC 2008-12-01
Σειρά:	Кардиоваскулярная терапия и профилактика
Θέματα:	chronic heart failure thrombophylia correction hemostasis metoprolol carvedilol
Διαθέσιμο Online:	https://cardiovascular.elpub.ru/jour/article/view/1686

Παρόμοια τεκμήρια

Target organs in patients with post-infarction chronic heart failure: dynamics during complex therapy including beta-adrenoblockers
ανά: I. P. Rubesh, κ.ά.
Έκδοση: (2008-08-01)

Outcomes of beta-blocker pharmacotherapy in patients with heart failure
ανά: Maletin Sanja D., κ.ά.
Έκδοση: (2024-01-01)

METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER
ανά: B. N. Garifullin, κ.ά.
Έκδοση: (2016-01-01)

BETA-ADRENOBLOCKERS AND PLATELET AGGREGATION. CARVEDILOL
ανά: A. N. Zakirova, κ.ά.
Έκδοση: (2016-01-01)

EFFECTS OF CARVEDILOL AND METOPROLOL ON VEGETATIVE REGULATION OF HEART AND MICROCIRCULATION IN PATIENTS WITH HYPERTENSION AND HIGH BODY MASS
ανά: A. R. Kiselev, κ.ά.
Έκδοση: (2016-01-01)

Long‐Term Mortality Associated With Use of Carvedilol Versus Metoprolol in Heart Failure Patients With and Without Type 2 Diabetes: A Danish Nationwide Cohort Study
ανά: Brian Schwartz, κ.ά.
Έκδοση: (2021-09-01)

EFFECTS OF CARVEDILOL ON PLATELET AGGREGATION IN MEN WITH ST-ELEVATION ACUTE MYOCARDIAL INFARCTION
ανά: A. N. Zakirova, κ.ά.
Έκδοση: (2016-01-01)

COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL
ανά: S. Y. Martsevich, κ.ά.
Έκδοση: (2016-01-01)

COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL
ανά: S. Y. Martsevich, κ.ά.
Έκδοση: (2016-01-01)

ANTIHYPERTENSIVE AND ANTIOXIDATIVE EFFECTS OF CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT/OBESITY
ανά: V. A. Nevzorova, κ.ά.
Έκδοση: (2016-01-01)

BETA-ADRENOBLOCKERS IN XXI CENTURY: EPOCH END OR IMMORTALITY BEGINNING? A VIEW OF ORDINARY CARDIOLOGIST
ανά: L. N. Malaj
Έκδοση: (2016-01-01)

PHARMACOECONOMIC ANALYSIS OF CARVEDILOL THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC RISK FACTORS (ACCORDING TO THE CAMELLIA STUDY)
ανά: S. Y. Martsevich, κ.ά.
Έκδοση: (2016-01-01)

Carvedilol and metoprolol are both able to preserve myocardial function in type 2 diabetes
ανά: Carol T. Bussey, κ.ά.
Έκδοση: (2020-03-01)

HOLTER ECG MONITORING AND TREATMENT EFFECTIVENESS CONTROL IN PATIENTS AFTER MYOCARDIAL INFARCTION
ανά: U. A. Islamova, κ.ά.
Έκδοση: (2010-12-01)

Comparing the effects of various β-blockers on cardiovascular mortality in breast cancer patients
ανά: Mantasha Tabassum, κ.ά.
Έκδοση: (2024-03-01)

COMPARATIVE EFFECTIVENESS OF DIFFERENT DRUG COMBINATIONS IN REGARD TO END-POINT INCIDENCE DURING POST-INFARCTION PERIOD
ανά: R. M. Gafurova, κ.ά.
Έκδοση: (2011-08-01)

Efficacy and safety of the first made in Russia alpha, beta long-acting adrenoblocker proxodolol in patients with arterial hypertension of the second degree
ανά: S A Belyaeva, κ.ά.
Έκδοση: (2011-04-01)

Carvedilol versus Metoprolol in Patients with Ventricular Tachyarrhythmias
ανά: Tobias Schupp, κ.ά.
Έκδοση: (2022-08-01)

The discovery of beta-blockers
ανά: Subir Kumar Maulik
Έκδοση: (2018-01-01)

Current guidelines for β-adrenoblockers use in cardiovascular diseases: focus on metoprolol succinate CR/XL: A review
ανά: Marina G. Bubnova
Έκδοση: (2022-07-01)

EFFECTS OF Β-ADRENOBLOCKERS ON MYOCARDIAL REMODELING, IMMUNO-INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE
ανά: A. N. Zakirova, κ.ά.
Έκδοση: (2015-12-01)

WHAT DOES PROVIDE A CLINICAL EFFICACY OF METOPROLOL?
ανά: E. V. Kuleshova
Έκδοση: (2016-01-01)

Hypotensive efficacy and cerebroprotective action of beta blocker metoprolol
ανά: N. L. Afanasyeva, κ.ά.
Έκδοση: (2005-02-01)

COMPARATIVE STUDY OF NEW DRUG OF LONG ACTING METOPROLOL TARTRATE - EGILOK RETARD AND ORIGINAL DRUG OF METOPROLOL SUCCINATE – BETALOC ZOK IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION
ανά: J. V. Lukina, κ.ά.
Έκδοση: (2015-12-01)

HEART FAILURE, DIABETES, BETA-BLOCKERS AND RISK OF HYPOGLYCEMIA
ανά: A. A. Aleksandrov, κ.ά.
Έκδοση: (2016-01-01)

Formulation and evaluation of carvedilol microcapsules using Eudragit NE30D and sodium alginate
ανά: Trishna Bal, κ.ά.
Έκδοση: (2013-12-01)

Diagnosis and Correction of Hemostatic Disorders in Severe Brain Injury
ανά: Ye. A. Kameneva, κ.ά.
Έκδοση: (2006-02-01)

BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL
ανά: I. T. Murkamilov, κ.ά.
Έκδοση: (2017-07-01)

Genetic Polymorphism of beta1-adrenergic Receptors and the Effect on the Clinical Efficacy of beta-adrenoblockers
ανά: V. N. Larina, κ.ά.
Έκδοση: (2021-11-01)

Topical issues of beta-blockers use in various clinical situations
ανά: D. V. Nebieridze
Έκδοση: (2018-07-01)

THE ROLE OF CARVEDILOL IN THE PREVENTION OF CARDIOMYOCYTE APOPTOSIS CAUSED BY ACUTE MYOCARDIAL INFARCTION
ανά: A. N. Zakirova, κ.ά.
Έκδοση: (2017-12-01)

Involvement of alpha- and beta-adrenoceptors in the automaticity of the isolated guinea pig pulmonary vein myocardium
ανά: Masahiko Irie, κ.ά.
Έκδοση: (2017-04-01)

Diagnosis and Correction of Perioperative Hemostatic Disorders at Hepatic Surgery
ανά: N. Yu. Demidova, κ.ά.
Έκδοση: (2007-08-01)

THE USE OF INTRAVENOUS FORMS OF BETA-BLOCKERS IN ACUTE CORONARY SYNDROME
ανά: I. D. Astrakhantseva, κ.ά.
Έκδοση: (2017-06-01)

Disorders of the central nervous system cognitive and mnestic functions in genetic arterial hypertension and with the use of beta-blockers of different generations
ανά: A. O. Svitlytskyi, κ.ά.
Έκδοση: (2024-09-01)

Oral delivery of the non-β-blocking R-carvedilol enantiomer for skin cancer chemoprevention in SKH-1 mice
ανά: Pabitra K. Sardar, κ.ά.
Έκδοση: (2025-01-01)

A simple LC-MS/MS method for pharmacokinetic study of carvedilol and 4/-hydroxyphenyl carvedilol at a low dose
ανά: Wanna Eiamart, κ.ά.
Έκδοση: (2022-01-01)

Beta-adrenoblockers in cardiology practice
ανά: A. A. Garganeeva
Έκδοση: (2010-10-01)

The Role of Carvedilol in the Treatment of Dilated and Anthracyclines-Induced Cardiomyopathy
ανά: Makoto Kodama, κ.ά.
Έκδοση: (2011-05-01)

URODYNAMIC EFFECTS OF BETA-ADRENOBLOCKERS: NEBIVOLOL ADVANTAGES
ανά: M. P. Savenkov, κ.ά.
Έκδοση: (2016-01-01)